Potential Performance Comparison of TyG-BMI and Inflammatory-Lipid Indices for Predicting Incident MASLD in Patients with Chronic Hepatitis B
Background: Noninvasive predictors of incident metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with chronic hepatitis B (CHB) are limited. We evaluated the predictive value of the triglyceride-glucose body mass index (TyG-BMI) compared with that of inflammatory-lipid indices. Objectives: Th...